Compound information
- Natural Products
- ZC1589784
- Molecular Formula
- C20H20BrN3O4S
- Molecular Weight
- 477.03578922 g/mol
- Structure
-
- IUPAC Name
- N-[3-[4-(4-bromophenyl)sulfonylpiperazine-1-carbonyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C20H20BrN3O4S/c1-2-19(25)22-17-5-3-4-15(14-17)20(26)23-10-12-24(13-11-23)29(27,28)18-8-6-16(21)7-9-18/h2-9,14H,1,10-13H2,(H,22,25)
- InChI Key
- HBEQICMVWPUCTA-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1cccc(C(=O)N2CCN(S(=O)(=O)c3ccc(Br)cc3)CC2)c1
- Source
- ZINC002325888894
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 29 | Ring Count | 3 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 86.79 Å2 | LogP | 2.717 |
LogS | -4.245 | LogD | 3.005 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.02 | Pgp substrate | 0.664 |
HIA | 0.965 | F20 % | 0.99 |
F30 % | 0.536 | Caco-2 | -4.459 |
MDCK | -5.069 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.138 | PPB | 98.016 |
VD | 0.549 | Fu | 1.866 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.071 | CYP1A2 substrate | 0.66 |
CYP2A6 substrate | 0.543 | CYP2B6 substrate | 0.618 |
CYP2C19 inhibitor | 0.555 | CYP2C19 substrate | 0.893 |
CYP2C8 substrate | 0.84 | CYP2C9 inhibitor | 0.598 |
CYP2C9 substrate | 0.996 | CYP2D6 inhibitor | 0.054 |
CYP2D6 substrate | 0.911 | CYP2E1 substrate | 0.94 |
CYP3A4 inhibitor | 0.285 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.191 | CL | 0.616 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.03 | Hepatotoxicity | 0.937 |
Mutagenicity | 0.002 | Rat Oral Acute Toxicity | 0.108 |
FDAMDD | 0.637 | Skin Sensitization | 0.696 |
Carcinogenicity | 0.279 | Eye Corrosion | 0.007 |
Eye Irritation | 0.163 | Respiratory Toxicity | 0.019 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.559 | IGC50 | 3.917 |
LC50FM | -3.473 | LC50DM | 1.345 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.105 | NR-AR-LBD | 0.395 |
NR-AhR | 0.222 | NR-Aromatase | 0.056 |
NR-ER | 0.397 | NR-ER-LBD | 0.452 |
NR-PPAR-gamma | 0.32 | SR-ARE | 0.859 |
SR-ATAD5 | 0.403 | SR-HSE | 0.09 |
SR-MMP | 0.206 | SR-p53 | 0.07 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.